Author

L. Guarneri

Observed name: L Guarneri

Observed institutions: Università degli Studi di Enna Kore, University of Palermo

OpenAlex ID: A5109799809

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

2018 · Vincenza Calvaruso, Giuseppe Cabibbo, et al. · Gastroenterology · 376

Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort

2018 · V. Calvaruso, S. Petta, et al. · Digestive and Liver Disease · 7

Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort

2018 · V. Calvaruso, S. Petta, et al. · Journal of Hepatology · 6

Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)

2017 · V. Calvaruso, G. Cabibbo, et al. · Digestive and Liver Disease · 5

Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals

2017 · V. Calvaruso, G. Cabibbo, et al. · Journal of Hepatology · 4

Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)

2017 · G. Cabibbo, I. Cacciola, et al. · Digestive and Liver Disease · 3

Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry

2017 · I. Cacciola, S. Petta, et al. · Digestive and Liver Disease · 2

Non-invasive tools to ruling out large varices: RESIST-HCV vs. Baveno VI criteria in a large cohort of patients with HCV cirrhosis

2017 · V. Calvaruso, I. Cacciola, et al. · Journal of Hepatology · 2

Pc.01.10 Liver and Cardiovascular Mortality After Daas: Data From the Resist-hcv Cohort

2019 · B. Magro, V. Calvaruso, et al. · Digestive and Liver Disease · 1

Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort

2017 · S. Madonia, V. Calvaruso, et al. · Journal of Hepatology · 1

Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort

2019 · I. Cacciola, S. Petta, et al. · Digestive and Liver Disease

Non-invasive tools to ruling out large varices: RESIST-HCV vs Baveno VI criteria in a large cohort of patients with HCV cirrhosis

2017 · V. Calvaruso, I. Cacciola, et al. · Digestive and Liver Disease

Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

2017 · G. Cabibbo, I. Cacciola, et al. · Journal of Hepatology

Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily Registry

2017 · I. Cacciola, S. Petta, et al. · Journal of Hepatology

Treatment of elderly HCV patients with severe fibrosis: safety and efficacy data from RESIST-HCV, a large regional database

2016 · V. Di Marco, G. Squadrito, et al. · Digestive and Liver Disease

Test for CCR5 tropism and treatment with maraviroc in Sicily: an observational retrospective multicentre study

2012 · B Celesia, M Gussio, et al. · Journal of the International AIDS Society

Works count: 16

Citation count: 407

H-index: 4

I10-index: 1